Calcium/Calmodulin-Stimulated Protein Kinase II (CaMKII): Different Functional Outcomes from Activation, Depending on the Cellular Microenvironment
Cells · 23.01.2023 · 12 (3) · 401
DOI: 10.3390/cells12030401 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 23.01.2023. Verfasst von John A P Rostas und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Pharmacy, College of Health Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW 2308, Australia. Hauptthemen laut MEDLINE: Calcium-Calmodulin-Dependent Protein Kinase Type 2, Calmodulin. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Calcium/calmodulin-stimulated protein kinase II (CaMKII) is a family of broad substrate specificity serine (Ser)/threonine (Thr) protein kinases widely expressed in many tissues that is capable of mediating diverse functional responses depending on its cellular and molecular microenvironment. This review briefly summarises current knowledge on the structure and regulation of CaMKII and focuses on how the molecular environment, and interaction with binding partner proteins, can produce different populations of CaMKII in different cells, or in different subcellular locations within the same cell, and how these different populations of CaMKII can produce diverse functional responses to activation following an increase in intracellular calcium concentration. This review also explores the possibility that identifying and characterising the molecular interactions responsible for the molecular targeting of CaMKII in different cells in vivo, and identifying the sites on CaMKII and/or the binding proteins through which these interactions occur, could lead to the development of highly selective inhibitors of specific CaMKII-mediated functional responses in specific cells that would not affect CaMKII-mediated responses in other cells. This may result in the development of new pharmacological agents with therapeutic potential for many clinical conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences and Pharmacy, College of Health Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW 2308, Australia.
- Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia.
ORCID-Profile: Kathryn A Skelding
Zitieren
APA
Rostas, J. A. P., & Skelding, K. A. (2023). Calcium/Calmodulin-Stimulated Protein Kinase II (CaMKII): Different Functional Outcomes from Activation, Depending on the Cellular Microenvironment. Cells, 12(3), 401. https://doi.org/10.3390/cells12030401
Vancouver
Rostas JAP, Skelding KA. Calcium/Calmodulin-Stimulated Protein Kinase II (CaMKII): Different Functional Outcomes from Activation, Depending on the Cellular Microenvironment. Cells. 2023;12(3):401. doi:10.3390/cells12030401
BibTeX
@article{Rostas2023,
author = {Rostas, John A P and Skelding, Kathryn A},
title = {Calcium/Calmodulin-Stimulated Protein Kinase II (CaMKII): Different Functional Outcomes from Activation, Depending on the Cellular Microenvironment},
journal = {Cells},
year = {2023},
volume = {12},
number = {3},
pages = {401},
doi = {10.3390/cells12030401}
}
EUVIMED